Candel Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Candel Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q2 2024.
  • Candel Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 31.1M shares, a 7.42% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 31.1M +2.14M +7.42% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 29.3M +428K +1.48% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 29.1M +171K +0.59% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 28.9M +27.9K +0.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 28.9M +27.9K +0.1% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 28.9M +227K +0.79% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 28.9M +230K +0.8% Dec 31, 2022 10-K 2024-03-28
Q3 2022 28.9M +202K +0.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 28.9M +17.2M +146% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 28.7M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 28.7M +17.1M +147% Dec 31, 2021 10-K 2023-03-30
Q3 2021 28.7M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 11.7M Jun 30, 2021 10-Q 2021-09-08
Q4 2020 11.6M Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.